{
  "ticker": "RGEN",
  "company_name": "Repligen Corporation",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT00060515",
      "title": "RG2133 (2',3',5'-Tri-O-Acetyluridine) in Mitochondrial Disease",
      "status": "TERMINATED",
      "phase": "PHASE1",
      "condition": "Mitochondrial Diseases",
      "start_date": "",
      "completion_date": "",
      "enrollment": 0,
      "sponsor": "Repligen Corporation"
    },
    {
      "nct_id": "NCT00812058",
      "title": "A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Bipolar I Depression",
      "start_date": "2008-11",
      "completion_date": "2010-12",
      "enrollment": 0,
      "sponsor": "Repligen Corporation"
    },
    {
      "nct_id": "NCT00076934",
      "title": "Safety of RG2077 in Patients With Multiple Sclerosis",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting",
      "start_date": "2003-01",
      "completion_date": "2006-02",
      "enrollment": 0,
      "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)"
    },
    {
      "nct_id": "NCT00322764",
      "title": "Phase II Study to Assess RG2417 in the Treatment of Bipolar I Depression",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Bipolar Depression",
      "start_date": "2006-03",
      "completion_date": "",
      "enrollment": 0,
      "sponsor": "Repligen Corporation"
    },
    {
      "nct_id": "NCT00036244",
      "title": "Synthetic Human Secretin in Children With Autism",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Autism",
      "start_date": "2002-04",
      "completion_date": "2004-01",
      "enrollment": 0,
      "sponsor": "Repligen Corporation"
    },
    {
      "nct_id": "NCT00036231",
      "title": "Synthetic Human Secretin in Children With Autism and Gastrointestinal Dysfunction",
      "status": "TERMINATED",
      "phase": "PHASE3",
      "condition": "Autism",
      "start_date": "2002-04",
      "completion_date": "",
      "enrollment": 0,
      "sponsor": "Repligen Corporation"
    },
    {
      "nct_id": "NCT01371240",
      "title": "Secretin-Assisted Computed Tomography Scan and Magnetic Resonance Imaging in Improving Pancreatic Tumor Conspicuity",
      "status": "WITHDRAWN",
      "phase": "EARLY_PHASE1",
      "condition": "Pancreas Cancer",
      "start_date": "2011-06",
      "completion_date": "2012-06",
      "enrollment": 0,
      "sponsor": "University Hospitals Cleveland Medical Center"
    },
    {
      "nct_id": "NCT00235274",
      "title": "Effects of RG1068 (Secretin) on Information Processing in Schizophrenia",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Schizophrenia",
      "start_date": "2005-11",
      "completion_date": "2006-08",
      "enrollment": 0,
      "sponsor": "Indiana University School of Medicine"
    },
    {
      "nct_id": "NCT00216294",
      "title": "Safety Study of the Drug RG1068 in Patients With Obsessive Compulsive Disorder",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Obsessive Compulsive Disorder (OCD)",
      "start_date": "2005-02",
      "completion_date": "2006-04",
      "enrollment": 0,
      "sponsor": "Indiana University School of Medicine"
    },
    {
      "nct_id": "NCT00660335",
      "title": "Safety and Efficacy of Synthetic Human Secretin-Enhanced MRCP in Subjects With Abnormalities of the Pancreas",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Pancreatitis",
      "start_date": "2008-03",
      "completion_date": "2009-10",
      "enrollment": 0,
      "sponsor": "Repligen Corporation"
    }
  ],
  "summary": {
    "total_trials": 10,
    "by_phase": {
      "PHASE1": 2,
      "PHASE2": 4,
      "PHASE3": 3,
      "EARLY_PHASE1": 1
    },
    "by_status": {
      "TERMINATED": 2,
      "COMPLETED": 7,
      "WITHDRAWN": 1
    },
    "active_trials": 0,
    "completed_trials": 7,
    "conditions": [
      "Autism",
      "Bipolar Depression",
      "Bipolar I Depression",
      "Mitochondrial Diseases",
      "Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting",
      "Obsessive Compulsive Disorder (OCD)",
      "Pancreas Cancer",
      "Pancreatitis",
      "Schizophrenia"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:21:29.072748",
    "search_query": "Repligen Corporation",
    "url": "https://clinicaltrials.gov/search?term=Repligen+Corporation"
  }
}